February 2019 Vol 10, No 2
The authors report on the use of technology to reduce the administrative burden of tumor boards while improving the quality of care delivered.
Support from leadership is imperative for creation, continuation, and expansion of patient navigation.
Bluebird Bio develops plan to sell gene-replacement therapy with annual payments contingent on continued effectiveness
Results 1 - 13 of 13